rf-fullcolor.png

 

August 16, 2017
by Michael Mezher

ICH Details Pilot Training Programs for 2017

The International Council for Harmonization (ICH) has released details for five upcoming training programs in the US, Germany and Japan.

The training programs are part of a pilot initiative agreed to at ICH's management committee meeting in Osaka, Japan in November 2016, where members of the management committee launched the year-long pilot and set out criteria for the program.

Under the pilot, the ICH Training Subcommittee has partnered with a small group of training providers to put together "high quality programs based upon the scientific and regulatory principles outlined in ICH guidelines."

The first of these ICH-endorsed training events, a workshop on chemistry, manufacturing and controls (CMC) quality, was held over three days in Singapore last March.

The upcoming training courses cover a range of topics, including regulatory submissions in the electronic common technical document (eCTD) format, good clinical practice (GCP) training and good manufacturing practice (GMP) for active pharmaceutical ingredients (APIs).

The topics for the training courses were selected based on the results of a survey given to industry and regulators to identify the areas where training is most needed.

Details for the courses are listed below, though a full program is not yet available for two of the events:

Following the pilot, ICH says it will look into the outcomes of the training sessions to inform its decisions for a longer-term training strategy.

ICH

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.